Wird geladen...
Hyperbilirubinemia without Transaminitis during Combined Therapy with Daclatasvir and Asunaprevir
Daclatasvir (DCV) and asunaprevir (ASV) are direct-acting antivirals (DAAs) used in the treatment of chronic hepatitis C virus (HCV) infection. Combined therapy with DCV and ASV shows high efficacy and safety even in patients with cirrhosis. We encountered a patient exhibiting severe hyperbilirubine...
Gespeichert in:
| Veröffentlicht in: | Case Rep Gastroenterol |
|---|---|
| Hauptverfasser: | , , , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
S. Karger AG
2016
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4965544/ https://ncbi.nlm.nih.gov/pubmed/27504082 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000447486 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|